- Home
- HOTH vs COSM Comparison
HOTH vs COSM Comparison
Compare HOTH & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- COSM
- Stock Information
- Founded
- HOTH 2017
- COSM 2009
- Country
- HOTH United States
- COSM United States
- Employees
- HOTH N/A
- COSM N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- HOTH Health Care
- COSM Health Care
- Exchange
- HOTH Nasdaq
- COSM Nasdaq
- Market Cap
- HOTH 8.3M
- COSM 8.2M
- IPO Year
- HOTH 2019
- COSM 2013
- Fundamental
- Price
- HOTH $0.86
- COSM $0.44
- Analyst Decision
- HOTH Strong Buy
- COSM
- Analyst Count
- HOTH 3
- COSM 0
- Target Price
- HOTH $4.00
- COSM N/A
- AVG Volume (30 Days)
- HOTH 643.5K
- COSM 285.8K
- Earning Date
- HOTH 05-13-2025
- COSM 04-16-2025
- Dividend Yield
- HOTH N/A
- COSM N/A
- EPS Growth
- HOTH N/A
- COSM N/A
- EPS
- HOTH N/A
- COSM N/A
- Revenue
- HOTH N/A
- COSM $54,426,402.00
- Revenue This Year
- HOTH N/A
- COSM $28.14
- Revenue Next Year
- HOTH N/A
- COSM N/A
- P/E Ratio
- HOTH N/A
- COSM N/A
- Revenue Growth
- HOTH N/A
- COSM 1.97
- 52 Week Low
- HOTH $0.58
- COSM $0.28
- 52 Week High
- HOTH $3.80
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- HOTH 44.77
- COSM 47.00
- Support Level
- HOTH $0.74
- COSM $0.28
- Resistance Level
- HOTH $0.84
- COSM $0.43
- Average True Range (ATR)
- HOTH 0.08
- COSM 0.05
- MACD
- HOTH 0.01
- COSM 0.01
- Stochastic Oscillator
- HOTH 76.04
- COSM 74.00
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.